Chemotherapy and heart damage risk

Some cancer treatments can affect the heart, but most people who have chemotherapy do not develop heart problems. The risk depends mainly on which medicines are used, the total amount received over the whole course, whether radiotherapy is given near the heart, and your own heart health before treatment. Doctors know which treatments carry more risk, and they plan and monitor with that in mind.

The medicine groups most often linked with heart effects are anthracyclines, such as doxorubicin and epirubicin, and some targeted treatments, such as trastuzumab, which is used for certain breast and stomach cancers. A few other medicines can occasionally cause chest pain, rhythm changes or high blood pressure. This is why many people have a heart scan, called an echocardiogram or echo, before starting, and sometimes during treatment. It gives a baseline so that any change can be picked up early, while it is easier to manage.

Many heart effects improve

Effects linked to targeted treatments often improve when treatment is paused or heart medicines are given. Some anthracycline effects can be longer lasting, which is why the total amount is carefully tracked.

Your existing health matters

High blood pressure, diabetes, previous heart disease, smoking and older age all raise the risk, and your team takes them into account.

Monitoring is protection

Heart checks are not a sign that something is wrong. They let your team act early if anything changes.

It cannot tell you your personal heart risk. That depends on your exact treatment, the total amount planned, radiotherapy, your age and your heart health. Your oncologist can explain your risk and why particular checks are planned.

It also cannot tell you whether to have or avoid a particular medicine. Never stop or change treatment because of worry about the heart. Discuss concerns with your team, who can balance the benefit against the risk.

Why an echo was done before treatment

A baseline scan shows how well your heart pumps before treatment, so later scans can be compared and small changes spotted early.

Blood pressure and sugar control help

Keeping blood pressure, diabetes and cholesterol well controlled during and after treatment reduces strain on the heart.

Smoking adds to the risk

Stopping smoking protects the heart and lungs and helps recovery. Ask your team for support to quit.

Effects can appear later

Some anthracycline heart effects show up years after treatment. Tell any doctor you see in future that you had these medicines.

Children and young adults need long-term follow-up

People treated as children or young adults may be offered heart checks for many years afterwards.

Heart specialists can work with your oncologist

For people with higher risk, a cardiologist with experience in cancer care can help plan monitoring and treatment.

Staying active supports the heart

Gentle regular activity, as agreed with your team, supports heart health and energy during and after treatment.

Keep your treatment summary

Ask for a written summary listing the medicines you received. It helps future doctors understand your heart history.

Ask about the total amount planned

For anthracyclines, it is reasonable to ask how much is planned over the whole course and how it compares with safer limits. Your oncologist can explain why that amount was chosen.

Report symptoms between checks

Heart scans happen at set times, but symptoms can appear in between. Breathlessness, swelling or palpitations should be reported without waiting for the next scan.

What to do next

Tell your team about any heart condition, blood pressure or diabetes, and ask which of your medicines can affect the heart and what monitoring is planned. Keep your appointments for heart scans, report breathlessness, swelling or chest pain promptly, and keep a copy of your treatment summary.